During the past decade, Bridge HIV, San Francisco Department of Public Health conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bridge HIV, San Francisco Department of Public Health" #1 sponsor was "Public Health Foundation Enterprises, Inc." with 7 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials sponsored, "San Francisco Department of Public Health" with 2 trials sponsored, "HIV Vaccine Trials Network" with 1 trials sponsored and "VaxGen" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bridge HIV, San Francisco Department of Public Health" #1 collaborator was "San Francisco Department of Public Health" with 7 trials as a collaborator, "University of California, San Francisco" with 4 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 3 trials as a collaborator, "AiCure" with 2 trials as a collaborator and "Emory University" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Bridge HIV, San Francisco Department of Public Health" are "HIV Infections" (9 trials), "HIV Prevention" (4 trials), "Pre-Exposure Prophylaxis" (4 trials), "Adherence, Medication" (3 trials) and "Risk Behavior" (2 trials). Many other conditions were trialed in "Bridge HIV, San Francisco Department of Public Health" in a lesser frequency.

Most popular intervention types in "Bridge HIV, San Francisco Department of Public Health" are "Behavioral" (6 trials), "Drug" (5 trials), "Other" (4 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Emtricitabine / Tenofovir Disoproxil Oral Tablet" (3 trials), "DOT Diary mobile app" (2 trials), "Abacavir sulfate" (1 trials), "Adapted Personalized Cognitive Risk-reduction Counseling intervention (PCC)" (1 trials) and "Amprenavir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bridge HIV, San Francisco Department of Public Health" are 10 trials for "All" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Bridge HIV, San Francisco Department of Public Health". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Bridge HIV, San Francisco Department of Public Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bridge HIV, San Francisco Department of Public Health, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".